Series A · Healthtech
ReEmerge raises $37m Series A for clinical development
Cognitive Network Restoration Therapy focuses on viable pathways in the central thalamus.
The Vertical Group, Dendrion Ventures, Oxford Science Enterprises, IAG Capital Partners and 415 Capital also participated.
The company plans to expand operations and development of Cognitive Network Restoration Therapy.
The approach targets underactive but viable central-thalamic circuits after brain injury. It remains in clinical development; the financing does not establish a therapeutic outcome.
Use of funds
Expand operations and development
Funding history
Series A · This round$37M